Robot Application for Hepatopancreatic Disorders, Gastroesophageal Reflux Disease, and Achalasia

Introduction We undertook this study to describe the number and variety of robotic operations undertaken for hepatopancreatic and esophageal disorders. Methods Data from 2015 through March of 2018 were analyzed for da Vinci™ robot application for hepatopancreatic disorders, gastroesophageal reflux disease (GERD), and achalasia. Results From 2015 through 2017, robotic hepatopancreatic operations increased 49%, robotic hepatic operations increased 107%, and robotic pancreatic operations increased 26%. Quarter after quarter, robotic application increased for hepatopancreatic operations, hepatic operations, and pancreatic operations ( P < .001 for each) with acceleration over the most recent months. The application of the Xi robot platform increased from 12% of robotic hepatopancreatic operations in 2015-71% in 2018 (1075% increase in numbers). From 2015 through 2017, robotic fundoplications and myotomies increased by 55%, robotic fundoplications increased by 59%, and robotic Heller myotomies increased by 211%. Quarter after quarter, robotic application increased for fundoplications and Heller myotomies ( P < .001 for each) with acceleration over the most recent months. The application of the Xi robot platform increased from 13% of these robotic operations in 2015-64% in 2018 (935% increase in numbers). Less than 10% of hepatopancreatic operations, fundoplications, and myotomies are undertaken robotically. Conclusions There has been an accelerating increase in the number of robotic operations for hepatopancreatic disorders, GERD, and achalasia over the past 3 ¼ years. Application of the Xi robot has dramatically increased, both absolutely and relatively. Still only a small proportion of operations for hepatopancreatic disorders, GERD, and achalasia use the robotic platform; this is changing fast.

Download Full-text

Surgical Treatment of Gastroesophageal Reflux Disease and Upside-down Stomach Using the Da Vinci® Robotic System. A Prospective Study

Journal of Gastrointestinal Surgery ◽

10.1007/s11605-007-0400-z ◽

2007 ◽

Vol 12 (3) ◽

pp. 504-509 ◽

Cited By ~ 19

Author(s):

Jens Hartmann ◽

Christoph A. Jacobi ◽

Charalambos Menenakos ◽

Mahmoud Ismail ◽

Chris Braumann

Keyword(s):

Surgical Treatment ◽

Gastroesophageal Reflux Disease ◽

Gastroesophageal Reflux ◽

Prospective Study ◽

Reflux Disease ◽

Da Vinci ◽

Robotic System ◽

System A ◽

A Prospective Study

Download Full-text

Stretta Radiofrequency Treatment for GERD: A Safe and Effective Modality

Gastroenterology Research and Practice ◽

10.1155/2013/783815 ◽

2013 ◽

Vol 2013 ◽

pp. 1-8 ◽

Cited By ~ 20

Author(s):

Mark Franciosa ◽

George Triadafilopoulos ◽

Hiroshi Mashimo

Keyword(s):

Gastroesophageal Reflux Disease ◽

Gastroesophageal Reflux ◽

Reflux Disease ◽

Meta Analysis ◽

Gastrointestinal Disorders ◽

Lifestyle Modifications ◽

Endoscopic Procedures ◽

The Past

Gastroesophageal reflux disease is one of the leading gastrointestinal disorders. Current treatments include lifestyle modifications, pharmacological therapies, surgical fundoplications, and, more recently, endoscopic procedures. The rising concern of long-term side effects of the popular proton-pump inhibitors and the more recent evidence raising doubts about the durability of fundoplication have spurred reinterest in endoscopic procedures to treat reflux disorders. In the aftermath of several innovative antireflux procedures that were introduced and failed clinically or financially over the past decade, there is lingering confusion regarding the merits of the presently available interventions. This paper focuses on one endoscopic procedure, Stretta, which now enjoys the longest experience, a recent meta-analysis, and robust data supporting its safety, efficacy, and durability. Stretta reduces esophageal acid exposure, decreases the frequency of transient lower esophageal relaxation, increases patient satisfaction, decreases medication use, and improves quality of life. As such, this procedure remains a valuable nonsurgical treatment option in the management of gastroesophageal reflux disease.

Download Full-text

Evaluation of Barrett's Esophagus

Digestive Disease Interventions ◽

10.1055/s-0041-1726325 ◽

2021 ◽

Author(s):

Trent Walradt ◽

Mohammad Bilal ◽

Douglas K. Pleskow

Keyword(s):

Gastroesophageal Reflux Disease ◽

Gastroesophageal Reflux ◽

Barrett’S Esophagus ◽

Esophageal Adenocarcinoma ◽

Reflux Disease ◽

Barrett's Esophagus ◽

Squamous Epithelium ◽

The Past ◽

Screening And Surveillance ◽

Stratified Squamous Epithelium

AbstractBarrett's esophagus (BE) is the condition in which a metaplastic columnar epithelium that is predisposed to malignancy replaces the stratified squamous epithelium that normally lines the distal esophagus. BE develops as a consequence of chronic gastroesophageal reflux disease and predisposes to esophageal adenocarcinoma (EAC). Several societal guidelines recommend screening and surveillance for BE to reduce the risk of EAC and its related morbidity and mortality. Even among persons undergoing screening and surveillance, a substantial proportion of cases of EAC can be missed. Consequently, the armamentarium for the evaluation of BE has expanded rapidly over the past decade. In this article, we summarize the pathophysiology and diagnosis of BE. We also discuss the latest advancements in the evaluation of BE.

Download Full-text

Quality of life of the patients with gastroesophageal reflux disease in Serbia

Acta chirurgica iugoslavica ◽

10.2298/aci1403013d ◽

2014 ◽

Vol 61 (3) ◽

pp. 13-18

Author(s):

Igor Dragicevic ◽

Tamara Babic ◽

Goran Trajkovic ◽

Aleksandar Corac ◽

Milos Bjelovic

Keyword(s):

Health Care ◽

Primary Health Care ◽

Gastroesophageal Reflux Disease ◽

Gastroesophageal Reflux ◽

Health Care Providers ◽

Reflux Disease ◽

Care Providers ◽

The Past ◽

Primary Health ◽

Time Period

Gastroesophageal reflux disease (ERD) was often considered as a minor public health problem and its potential severity was not fully recognized by the general public, patients, the health care system, and in some cases health care providers. Data about GERD related HRQoL in eastern European population are scare. The aim of the study was to evaluate the burden of GERD on patients treated in Serbian primary health care. The study included 1091 patients with diagnosed GERD, treated in Serbian primary health care. All patients completed Serbian version of generic self-administered Center for Disease Control and Prevention questionnaire, CDC-HRQoL-4.In our study, 463 (42%) GERD patients self-rated their current health status as fair or poor, 584 (53%) had poor physical health one or more days during the past 30 days, 460 (42%) had poor mental health one or more days for the same time period. Due to disease symptoms 492 (46%) GERD patients felt depressed one or more days during the past 30 days, 581 (54%) felt tired or sleepy during the same time period. In addition, GERD patients had lower scores regarding number of healthy and unhealthy days. The obtained results had demonstrated that in large proportion, GERD impaired patient everyday lives. A better understanding of the relationships between GERD and impaired HRQoL may allow the physicians in primary health care to manage these patients more effectively in the future.

Download Full-text

Gastroesophageal Reflux Disease: Serious Illness Potential Often Misunderstood

ASHA Leader ◽

10.1044/leader.ftr1.11152006.6 ◽

2006 ◽

Vol 11 (15) ◽

pp. 6-21

Author(s):

Ellen N. Friedman

Keyword(s):

Gastroesophageal Reflux Disease ◽

Gastroesophageal Reflux ◽

Reflux Disease ◽

Serious Illness

Download Full-text

Gastroesophageal Reflux Disease: A Gastroenterologist's Perspective

Perspectives on Voice and Voice Disorders ◽

10.1044/vvd21.3.89 ◽

2011 ◽

Vol 21 (3) ◽

pp. 89-99

Author(s):

Michael F. Vaezi

Keyword(s):

Gastroesophageal Reflux Disease ◽

Gastroesophageal Reflux ◽

Reflux Disease ◽

Best Practice ◽

Clinical Care ◽

Diagnostic Testing ◽

Diagnostic Tools ◽

Swallowing Function ◽

Atypical Symptoms

Gastroesophageal reflux disease (GERD) is a commonly diagnosed condition often associated with the typical symptoms of heartburn and regurgitation, although it may present with atypical symptoms such as chest pain, hoarseness, chronic cough, and asthma. In most cases, the patient's reduced quality of life drives clinical care and diagnostic testing. Because of its widespread impact on voice and swallowing function as well as its social implications, it is important that speech-language pathologists (SLPs) understand the nature of GERD and its consequences. The purpose of this article is to summarize the nature of GERD and GERD-related complications such as GERD-related peptic stricture, Barrett's esophagus and adenocarcinoma, and laryngeal manifestations of GERD from a gastroenterologist's perspective. It is critical that SLPs who work with a multidisciplinary team understand terminology, diagnostic tools, and treatment to ensure best practice.

Download Full-text